Vivos Therapeutics (VVOS) Enterprise Value Growth (1y) (2020 - 2026)
Vivos Therapeutics (VVOS) Enterprise Value Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.65% |
| Dec 31, 2025 | 66.63% |
| Sep 30, 2025 | 50.79% |
| Jun 30, 2025 | 36.23% |
| Mar 31, 2025 | 11.54% |
| Dec 31, 2024 | -281.01% |
| Sep 30, 2024 | -537.65% |
| Jun 30, 2024 | -76.92% |
| Mar 31, 2024 | 62.86% |
| Dec 31, 2023 | 53.31% |
| Sep 30, 2023 | 85.30% |
| Jun 30, 2023 | 69.20% |
| Mar 31, 2023 | 60.74% |
| Dec 31, 2022 | 85.34% |
| Sep 30, 2022 | 76.42% |
| Jun 30, 2022 | 62.98% |
| Mar 31, 2022 | -26.44% |
| Dec 31, 2021 | -31.82% |
| Dec 31, 2020 | -3,778.96% |